Healthcare -
Biotechnology - NASDAQ - US
$ 37.67
0.106 %
$ 3 B
Market Cap
-10.05
P/E
AKRO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities AKRO - Akero Therapeutics, Inc.
446 M
LAST VALUE
32.06%
2 YEAR CAGR
35.95%
5 YEAR CAGR
0.00%
10 YEAR CAGR